Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 6/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | RARB | P10826 | 4/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12199924 | 0.94 | RARB (0.61) | CYP2D6CYP3A4CYP2C9CYP2C19CYP19A1 | |
| SCHEMBL95824 | 0.94 | SMN1; SMN2 (0.63) | CYP2D6CYP3A4CYP1A2LMNAMAPT | |
| SCHEMBL16561645 | 0.92 | CYP3A4 (0.53) | CYP2D6CYP3A4CYP2C9CYP2C19CYP19A1 | |
| SCHEMBL8348497 | 0.89 | NR5A1 (0.62) | LMNAMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL5583851 | 0.89 | CYP2D6 (0.76) | CYP2D6CYP3A4CYP2C9CYP2C19CYP19A1 | |
| SCHEMBL9151170 | 0.89 | CYP2D6 (0.76) | CYP2D6CYP3A4CYP2C9CYP2C19CYP19A1 | |
| SCHEMBL23350372 | 0.88 | NR5A1 (0.66) | LMNAMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL9072656 | 0.88 | NR5A1 (0.66) | LMNAMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL14608534 | 0.88 | NR5A1 (0.66) | LMNAMAPTSMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL12302872 | 0.88 | NR5A1 (0.66) | LMNAMAPTSMN1; SMN2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024665-B2 | Polymer-stabilized liquid crystal composition and use thereof | BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) | 2024-07-02 | — | — | US | disclosed |
| US-20110178306-A1 | Sulphonyl-1,2,4-Triazole Salts | PHOSTECH LITHIUM INC. (CA) | 2011-07-21 | — | — | US | disclosed |
| US-7700620-B2 | C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178306-A1 | Sulphonyl-1,2,4-Triazole Salts | TST, STS, SQOR | CYP2D6 517/4885CYP3A4 33/4885CYP2C9 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.